Tobradex ST Now Available for Inflammatory Eye Conditions With Bacterial Infection
Tobradex ST contains tobramycin, an antibacterial drug, and dexamethasone, a potent corticosteroid.
Ocular Infections
Avaclyr Approved for the Treatment of Acute Herpetic Keratitis
The Food and Drug Administration (FDA) has approved Avaclyr (acyclovir ophthalmic ointment; Fera Pharmaceuticals) 3% for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus.
USPSTF: Final Rec on Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum
Currently, the only drug approved by the Food and Drug Administration (FDA) for prophylaxis is erythromycin, a macrolide antibiotic.
Bacterial Conjunctivitis Treatment Currently in Shortage
Azasite, supplied as a 2.5mL solution, contains benzalkonium chloride. It is indicated for use in susceptible bacterial conjunctivitis.
Clinical Characteristics of Endogenous Endophthalmitis Examined in Injection Drug Users
Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention
Vancomycin-Associated HORV Prompts FDA Statement on Intraocular Use
Although not FDA-approved, intraocular vancomycin is often used during cataract surgery to prevent postoperative endophthalmitis.
Infection Risk Investigated for Processed Tissue in Corneal Transplants
The researchers found that donor rim culture results were three times more likely to be positive for fungi in endothelial keratoplasty-processed eyes (1.14%) compared with other uses (0.37%).
Clinicians Overprescribing Antibiotics for Common Eye Infection
Fifty-eight percent (n=198,462) of the total patients had filled ≥1 topical antibiotic prescription, of which approximately 20% (n=38,774) of patients filled prescriptions for combination antibiotic + corticosteroid products.
Uveitis Specialists, Rheumatologists Differ in Anterior Scleritits Tx Decisions
Uveitis specialists and rheumatologists differ significantly in their most-selected first-choice treatment option for patients with anterior scleritis, according to new findings from a survey by researchers at the University of Colorado.
Device to Treat Eustachian Tube Dysfunction Gains Approval
The Food and Drug Administration (FDA) has permitted the marketing of a novel balloon device, The Aera Eustachian Tube Balloon Dilation System (Acclarent), to treat persistent Eustachian tube dysfunction (ETD).
